Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis

참고문헌 (21)

1. European Association for the Study of the Liver, "EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection", J Hepatol, 67, pp.370~398 (2017)
2. Terrault NA, "AASLD guidelines for treatment of chronic hepatitis B", Hepatology, 63, pp.261~283 (2016)
3. Sarin SK, "Asian-Pacific clinical practice guidelines on the management of hepatitis B : a 2015 update", Hepatol Int, 10, pp.1~98 (2016)
4. European Association for the Study of the Liver, "EASL clinical practice guidelines : management of chronic hepatitis B virus infection", J Hepatol, 57, pp.167~185 (2012)
5. Wang L, "Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection", Hepatol Int, 10, pp.133~138 (2016)
6. Cornberg M, "The role of quantitative hepatitis B surface antigen revisited", J Hepatol, 66, pp.398~411 (2017)
7. Jia W, "Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B : a prospective observational study", Medicine, 93, pp.e322~ (2014)
8. Song LW, "Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection", Clin Microbiol Infect, 21, pp.197~203 (2015)
9. Yuan Q, "Total hepatitis B core antigen antibody, a quantitative non-invasive marker of hepatitis B virus induced liver disease", Plos One, 10, pp.e130209~ (2015)
10. Rokuhara A, "Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment", J Viral Hepat, 10, pp.324~330 (2003)
11. Suzuki F, "Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients", J Med Virol, 81, pp.27~33 (2009)
12. Kimura T, "Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain", J Biol Chem, 280, pp.21713~21719 (2005)
13. Seto WK, "Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B", Clin Microbiol Infect, 20, pp.1173~1180 (2014)
14. Maasoumy B, "Hepatitis B core-related antigen(HBcrAg)levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D", Clin Microbiol Infect, 21, pp.606.e1~606.e10 (2015)[DOI]
15. Brunt EM, "Grading and staging the histopathological lesions of chronic hepatitis : the Knodell histology activity index and beyond", Hepatology, 31, pp.241~246 (2000)
16. Martinot-Peignoux M, "Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients", J Hepatol, 58, pp.1089~1095 (2013)
17. Lebossé F, "Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B", J Hepatol, 66, pp.897~909 (2017)
18. Kondo Y, "Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection", ISRN Gastroenterol, 2013, pp.935295~ (2013)
19. Zhang ZQ, "Measurement of the hepatitis B core-related antigen is valuable for predicting the pathological status of liver tissues in chronic hepatitis B patients", J Virol Methods, 235, pp.92~98 (2016)
20. Horst AK, "Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells", Cell Mol Immunol, 13, pp.277~292 (2016)
21. Gou Y, "Predictive value of hepatitis B core-related antigen(HBcrAg)during the natural history of hepatitis B virus infection", Clin Lab, 63, pp.1063~1070 (2017)

관련 논문AI추천